Robin E. Miller, MD

Hematology/Oncology

Primary Office

Nemours Children's Hospital, Delaware Nemours Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803 Appointment: (800) 416-4441

Get to Know Me

As a doctor who treats children with cancer and chronic blood diseases, I don’t just treat the disease itself. I try to help the children and families I care for understand the illness, and find ways to cope so they can make the most of every day.

Why I Treat Children

I enjoy helping kids and nurturing them – and forming close relationships with families as they navigate their way through serious illness. Improving a child’s quality of life is one of the most satisfying things we try to do each day, and seeing a child become a productive, happy adult is what we live for.

What I'm Passionate About

As health care professionals, our mission is to do what’s best for our patients, and that priority comes first. I’m proud that Nemours treats patients without regard to their ability to pay for our services.

Education & Training

Fellowship

  • Pediatric Hematology/Oncology - Rainbow Babies & Children's Hospital, 1996

Internship

  • Pediatrics - Rainbow Babies & Children's Hospital, 1990

Residency

  • Pediatrics - Rainbow Babies & Children's Hospital, 1993

Medical/Dental School

  • MD - Temple University School of Medicine, 1989

Board Certifications

  • American Board of Pediatrics/Pediatric Hematology-Oncology

Awards & Recognition

  • 2015 SJ Magazine's Top Docs for Kids
  • 2014 SJ Magazine Top Doctors
  • 2009 Physician Excellence Award in End-Of-Life Care

Insurance Accepted

  • Aetna Better Health PA Kids HMO
  • Aetna HMO
  • Aetna PPO/EPO/POS
  • Aetna PPO/POS/EPO
  • Amerihealth Caritas Delaware
  • Amerihealth Caritas Delaware NJ
  • Carefirst MD Community Health Plan Mcaid
  • Cigna & Great West HMO/POS/EPO
  • Cigna & Great West PPO
  • Cigna Lifesource Transplant
  • Cigna/Great West HMO EPO POS
  • Cigna/Great West PPO
  • Delaware First Health
  • Delaware Medicaid/Diamond State
  • Delaware Medicare
  • Devon Health Services
  • Fidelis Care NJ Medicaid HMO
  • First Health/Affordable PPO
  • Geisinger Health Plan Commercial
  • Global Medical Managment DE/PA
  • Global Medical Mangment NJ
  • Health Partners Medicaid/Kidz Partner HMO
  • Highmark Blue Cross Blue Shield of Delaware
  • Highmark Medicaid Health Options
  • Horizon Blue Cross Blue Shield of New Jersey
  • IBC Amerihealth Keystone HMO/PPO [Delaware Locations]
  • Independance Blue Cross/Amerihealth/Keystone Health Plan
  • Insurance Administrators of America
  • INTEGRA Administrative Group (ClaimsBridge)
  • Keystone First Medicaid HMO
  • Lifetrac Transplant
  • Maryland Medicaid
  • Multiplan PPO
  • National Transplant (Humana)
  • New Jersey Medicaid
  • Olympus Managed Healthcare PPO NJ
  • Pennsylvania Medicaid
  • Plan Vista/NPPN PPO
  • Preferred Healthcare PPO
  • Private Health Care Systems (PHCS)
  • Private Healthcare Systems (PHCS)
  • Qualcare HMO/POS/PPO
  • Star Healthcare Network
  • Star Healthcare Network
  • Three Rivers Provider Network
  • Tricare/Humana Military Health Services
  • United Healthcare of the Mid-Atlantic
  • UPMC MCAID/CHIP PA DE
  • Wellpoint Maryland Medcaid

  • Blood Disorders
  • Bone Tumors
  • Cancer Care
  • Hemophilia
  • Immune Thrombocytopenia
  • Lymphoma
  • Neutropenia
  • Platelet Abnormalities
  • Sickle Cell Disease
  • Solid Tumors

Medical Interests

  • Hemoglobinopathies
  • Hodgkin's lymphoma
  • Malignant bone tumors

  • Monitoring retinal pathology and cerebral injury in sickle cell disease using spectral-domain optical coherence tomography in pediatric patients; Pediatric Blood and Cancer; (2021).

    View Full Publication
  • Psychosocial screening in sickle cell disease: Validation of the psychosocial assessment tool; Journal of Pediatric Psychology; (2020).

    View Full Publication
  • A Complicated Case of Vaccine Refusal; Pediatrics; (2020).

    View Full Publication
  • Family Resilience from the Perspective of Caregivers of Youth with Sickle Cell Disease; Journal of Pediatric Hematology/Oncology; (2020).

    View Full Publication
  • Implementation of a learning healthcare system for sickle cell disease; JAMIA Open; (2020).

    View Full Publication
  • Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia; Prostaglandins Leukotrienes and Essential Fatty Acids; (2019).

    View Full Publication
  • Quantitative sensory testing in children with sickle cell disease: additional insights and future possibilities; British Journal of Haematology; (2019).

    View Full Publication
  • Funduscopic examination and SD-OCT in detecting sickle cell retinopathy among pediatric patients; Journal of AAPOS; (2018).

    View Full Publication
  • Caregiver perspectives on family psychosocial risks and resiliencies in pediatric sickle cell disease: Informing the adaptation of the Psychosocial Assessment Tool.; Clinical Practice in Pediatric Psychology; (2017).

    View Full Publication
  • Posterior reversible encephalopathy syndrome and cerebral sinus thrombosis in a case of pediatric B-Cell ALL; Journal of Pediatric Hematology/Oncology; (2017).

    View Full Publication
  • Loss of Major DNase I Hypersensitive Sites in Duplicated β-globin Gene Cluster Incompletely Silences HBB Gene Expression; Human Mutation; (2016).

    View Full Publication
  • Update on Pediatric Leukemia and Lymphoma Imaging; Seminars in Ultrasound, CT and MRI; (2013).

    View Full Publication
  • Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: Results of a feasibility study (PROACTIVE); British Journal of Haematology; (2012).

    View Full Publication
  • Rituximab as potential therapy for paraneoplastic cerebellar degeneration in pediatric Hodgkin disease; Pediatric Blood and Cancer; (2012).

    View Full Publication
  • A rare case of osteosarcoma and rhabdomyosarcoma at the same site 7 years apart.; American journal of orthopedics (Belle Mead, N.J.); (2008).

    View Full Publication
  • Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45; Journal of Biological Chemistry; (2003).

    View Full Publication
  • Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation; Blood; (2003).

    View Full Publication
  • Reduced CTLA-4 protein and messenger RNA expression in umbilical cord blood T lymphocytes; Experimental Hematology; (2002).

    View Full Publication
  • Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes; Experimental Hematology; (2001).

    View Full Publication
  • Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes; Blood; (1999).

    View Full Publication
  • A receptor for the lipocalin placental protein 14 on human monocytes; FEBS Letters; (1998).

    View Full Publication
  • Transient erythroblastopenia of childhood in infants 6 months of age; Journal of Pediatric Hematology/Oncology; (1994).

    View Full Publication

  • English